Changes to the Code
S. 1785 · No Handouts for Drug Advertisements Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
26 U.S.C. § 280I Disallowance of deduction for direct-to-consumer advertising of certain drugs New section
1 change the bill asks for here, 1 carried out
- Carried out:
Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:280I. Disallowance of deduction for direct-to-consumer advertising of certain drugs (a) In general.— No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of covered drugs for any taxable year. (b) Direct-to-Consumer advertising.— For purposes of this section— (1) In general.— The term
direct-to-consumer advertising
means any dissemination, by or on behalf of a covered entity, of an advertisement which— (A) is in regard to a covered drug, and (B) primarily targeted to the general public, including through— (i) broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and (ii) dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications). (2) Exception.— Such term shall not include an advertisement made through publication in journals and other periodicals. (3) Other terms.— For purposes of this subsection— (A) Covered entity.— The termcovered entity
means— (i) a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or (ii) a person that owns an outsourcing facility (as such term is defined in section 503B(d)(4) of such Act), either directly or indirectly through a subsidiary. (B) Covered drug.— The termcovered drug
means— (i) a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or (ii) a drug compounded in accordance with section 503A or 503B of such Act..
§ 280I(a)–(b)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 280I. [inserted: Disallowance of deduction for direct-to-consumer advertising of certain drugs] | ||||
| (a) | (a) [inserted: In general.—] | |||
| [inserted: No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of covered drugs for any taxable year.] | ||||
| (b) | (b) [inserted: Direct-to-Consumer advertising.—] | |||
| [inserted: For purposes of this section—] | ||||
| (b)(1) | (1) [inserted: In general.—] | |||
| [inserted: The term “direct-to-consumer advertising” means any dissemination, by or on behalf of a covered entity, of an advertisement which—] | ||||
| (b)(1)(A) | (A) [inserted: ] | |||
| [inserted: is in regard to a covered drug, and] | ||||
| (b)(1)(B) | (B) [inserted: ] | |||
| [inserted: primarily targeted to the general public, including through—] | ||||
| (b)(1)(B)(i) | (i) [inserted: ] | |||
| [inserted: broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and] | ||||
| (b)(1)(B)(ii) | (ii) [inserted: ] | |||
| [inserted: dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications).] | ||||
| (b)(2) | (2) [inserted: Exception.—] | |||
| [inserted: Such term shall not include an advertisement made through publication in journals and other periodicals.] | ||||
| (b)(3) | (3) [inserted: Other terms.—] | |||
| [inserted: For purposes of this subsection—] | ||||
| (b)(3)(A) | (A) [inserted: Covered entity.—] | |||
| [inserted: The term “covered entity” means—] | ||||
| (b)(3)(A)(i) | (i) [inserted: ] | |||
| [inserted: a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or] | ||||
| (b)(3)(A)(ii) | (ii) [inserted: ] | |||
| [inserted: a person that owns an outsourcing facility (as such term is defined in section 503B(d)(4) of such Act), either directly or indirectly through a subsidiary.] | ||||
| (b)(3)(B) | (B) [inserted: Covered drug.—] | |||
| [inserted: The term “covered drug” means—] | ||||
| (b)(3)(B)(i) | (i) [inserted: ] | |||
| [inserted: a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), or] | ||||
| (b)(3)(B)(ii) | (ii) [inserted: ] | |||
| [inserted: a drug compounded in accordance with section 503A or 503B of such Act.] | ||||